Abstract
Interleukin-32 (IL-32) is a pro-inflammatory cytokine that was first characterized in2005.it was named IL-32 due to its potent pro-inflammatory effects. IL-32 does not contain a typical hydrophobic signal peptide at the N terminus for secretion, but IL-32 was detected in the supernatant of stimulated cells, how IL-32 is secreted is still not fully understood. Also, it is still unclear through which cell surface receptor IL-32 mediates its function. IL-32 may also have an important function as an intracellular protein55. IL-32, via interactions with some other molecules, has been reported to be involved in various intracellular signaling. The focus of the present review is on the properties of this cytokine in liver diseases. Understanding the involvement of IL-32 in the pathogenesis of liver diseases may assist in identifying novel therapeutic strategies to mitigate or prevent liver diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
